TY  - JOUR
AU  - Feldheim, Jonas
AU  - Schmidt, Teresa
AU  - Oster, Christoph
AU  - Feldheim, Julia
AU  - Stuschke, Martin
AU  - Stummer, Walter
AU  - Grauer, Oliver
AU  - Scheffler, Björn
AU  - Hagemann, Carsten
AU  - Sure, Ulrich
AU  - Kleinschnitz, Christoph
AU  - Lazaridis, Lazaros
AU  - Kebir, Sied
AU  - Glas, Martin
TI  - Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 Pandemic.
JO  - Cancers
VL  - 15
IS  - 16
SN  - 2072-6694
CY  - Basel
PB  - MDPI
M1  - DKFZ-2023-01739
SP  - 4054
PY  - 2023
AB  - In order to minimize the risk of infections during the COVID-19 pandemic, remote video consultations (VC) experienced an upswing in most medical fields. However, telemedicine in neuro-oncology comprises unique challenges and opportunities. So far, evidence-based insights to evaluate and potentially customize current concepts are scarce. To fill this gap, we analyzed >3700 neuro-oncological consultations, of which >300 were conducted as VC per patients' preference, in order to detect how both patient collectives distinguished from one another. Additionally, we examined patients' reasons, suitable/less suitable encounters, VC's benefits and disadvantages and future opportunities with an anonymized survey. Patients that participated in VC had a worse clinical condition, higher grade of malignancy, were more often diagnosed with glioblastoma and had a longer travel distance (all p < 0.01). VC were considered a fully adequate alternative to face-to-face consultations for almost all encounters that patients chose to participate in (>70
KW  - COVID-19 (Other)
KW  - SARS-CoV-2 (Other)
KW  - brain (Other)
KW  - cancer (Other)
KW  - consultations (Other)
KW  - glioma (Other)
KW  - oncology (Other)
KW  - video (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:37627083
C2  - pmc:PMC10452255
DO  - DOI:10.3390/cancers15164054
UR  - https://inrepo02.dkfz.de/record/282355
ER  -